• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急迫性尿失禁:作为膀胱过度活动症关键症状的评估综述。

Urinary urgency: a review of its assessment as the key symptom of the overactive bladder syndrome.

机构信息

Bristol Urological Institute, Southmead Hospital, Bristol, BS10 5NB, UK.

出版信息

World J Urol. 2012 Jun;30(3):385-92. doi: 10.1007/s00345-011-0742-8. Epub 2011 Aug 19.

DOI:10.1007/s00345-011-0742-8
PMID:21853323
Abstract

PURPOSE

Overactive bladder (OAB) is a common condition that is associated with a negative impact on quality of life. Urgency is the essential symptom when making a diagnosis, and its effective treatment is a principal aim in OAB management. However, urgency has often been relatively neglected as an outcome measure in clinical trials. The aim of this review is, first, to describe the background to urgency in OAB; second, to determine whether results provided by several tools used to measure urgency in clinical trials could be cross-related to each other in a meaningful way.

METHODS

The wording of various tools used to measure urgency in OAB was compared against the definition of urgency proposed by the International Continence Society (ICS). Urgency data were evaluated from two randomised, double-blinded, placebo-controlled trials with solifenacin in which seven tools were used to measure urgency as a primary or secondary outcome. In particular, subanalyses were available from these tools, which measured urgency equating to the ICS definition, excluding data points that could be interpreted as normal/strong desire to void.

RESULTS

Baseline scores for ICS-defined urgency differed between the tools, which might reflect imprecision in their wording and consequent overlap between urgency and normal/strong desire to void. All the tools detected broadly similar mean percentage reductions in the number of urgency episodes from baseline to the endpoint of the studies.

CONCLUSIONS

Urgency should be the primary or co-primary endpoint for future studies of OAB and detrusor overactivity. Greater clarity is needed in the development of instruments for measuring urgency, so that they do not confuse urgency with normal bladder sensations; more education and guidance are needed on how urgency is defined.

摘要

目的

膀胱过度活动症(OAB)是一种常见病症,会对生活质量产生负面影响。尿急是诊断的基本症状,有效治疗是 OAB 管理的主要目标。然而,在临床试验中,尿急往往相对被忽视为一种疗效评价指标。本综述旨在:首先,描述 OAB 中尿急的背景;其次,确定在临床试验中用于测量尿急的几种工具所提供的结果是否可以以有意义的方式相互关联。

方法

将用于测量 OAB 中尿急的各种工具的措辞与国际尿控协会(ICS)提出的尿急定义进行了比较。从两项使用索利那新的随机、双盲、安慰剂对照试验中评估了尿急数据,这两项试验将七种工具用于测量尿急作为主要或次要疗效评价指标。特别是,从这些工具中获得了亚分析,这些工具测量的尿急等同于 ICS 定义,排除了可以解释为正常/强烈尿意的数据点。

结果

根据工具的不同,ICS 定义的尿急的基线评分存在差异,这可能反映了措辞不够精确,以及尿急和正常/强烈尿意之间的重叠。所有工具都检测到了从基线到研究终点的尿急发作次数的平均百分比大致相似的降低。

结论

未来的 OAB 和逼尿肌过度活动研究应该将尿急作为主要或共同主要的疗效评价指标。在开发用于测量尿急的仪器时需要更加明确,以避免将尿急与正常膀胱感觉混淆;需要对如何定义尿急进行更多的教育和指导。

相似文献

1
Urinary urgency: a review of its assessment as the key symptom of the overactive bladder syndrome.急迫性尿失禁:作为膀胱过度活动症关键症状的评估综述。
World J Urol. 2012 Jun;30(3):385-92. doi: 10.1007/s00345-011-0742-8. Epub 2011 Aug 19.
2
Impact of solifenacin on diary-recorded and patient-reported urgency in patients with severe overactive bladder (OAB) symptoms.索利那新对伴有严重膀胱过度活动症(OAB)症状患者的日记记录和患者报告的急迫性的影响。
Curr Med Res Opin. 2010 Oct;26(10):2277-85. doi: 10.1185/03007995.2010.509582.
3
Redefining response in overactive bladder syndrome.重新定义膀胱过度活动症的反应。
BJU Int. 2007 Jan;99(1):101-6. doi: 10.1111/j.1464-410X.2007.06517.x.
4
Solifenacin in the treatment of urgency and other symptoms of overactive bladder: results from a randomized, double-blind, placebo-controlled, rising-dose trial.索利那新治疗膀胱过度活动症的尿急及其他症状:一项随机、双盲、安慰剂对照、剂量递增试验的结果
BJU Int. 2008 Nov;102(9):1120-7. doi: 10.1111/j.1464-410X.2008.07939.x. Epub 2008 Oct 6.
5
Efficacy and tolerability of solifenacin in elderly subjects with overactive bladder syndrome: a pooled analysis.索利那新治疗老年膀胱过度活动症患者的疗效和耐受性:一项汇总分析。
Am J Geriatr Pharmacother. 2006 Mar;4(1):14-24. doi: 10.1016/j.amjopharm.2006.03.004.
6
Solifenacin for overactive bladder: secondary analysis of data from VENUS based on baseline continence status.索利那新用于治疗膀胱过度活动症:基于VENUS研究基线尿失禁状态的数据二次分析
Int Urogynecol J. 2010 Jul;21(7):847-54. doi: 10.1007/s00192-010-1120-6. Epub 2010 Mar 26.
7
Recent developments in the management of overactive bladder: focus on the efficacy and tolerability of once daily solifenacin succinate 5 mg.膀胱过度活动症管理的最新进展:聚焦于每日一次服用5毫克琥珀酸索利那新的疗效和耐受性。
Curr Med Res Opin. 2005 Jan;21(1):71-80. doi: 10.1185/030079904x20268.
8
Randomized, double-blind, placebo- and propiverine-controlled trial of the once-daily antimuscarinic agent solifenacin in Japanese patients with overactive bladder.在日本膀胱过度活动症患者中进行的每日一次抗毒蕈碱药物索利那新的随机、双盲、安慰剂和丙哌维林对照试验。
BJU Int. 2007 Sep;100(3):579-87. doi: 10.1111/j.1464-410X.2007.07031.x.
9
Solifenacin for overactive bladder with incontinence: symptom bother and health-related quality of life outcomes.索利那新用于治疗伴有尿失禁的膀胱过度活动症:症状困扰及与健康相关的生活质量结果
Ann Pharmacother. 2007 Mar;41(3):391-8. doi: 10.1345/aph.1H581. Epub 2007 Mar 6.
10
Efficacy of solifenacin in patients with severe symptoms of overactive bladder: a pooled analysis.索利那新治疗膀胱过度活动症严重症状患者的疗效:一项汇总分析。
Curr Med Res Opin. 2006 Jan;22(1):41-8. doi: 10.1185/030079905X74907.

引用本文的文献

1
Association analysis of ADRB3:rs4994 with urodynamic outcome, six months after a single intra-detrusor injection of botulinum toxin, in women with overactive bladder.ADRB3:rs4994 与女性膀胱过度活动症单次膀胱内注射肉毒毒素后 6 个月尿动力学结果的关联分析。
Pharmacol Rep. 2024 Dec;76(6):1489-1500. doi: 10.1007/s43440-024-00647-9. Epub 2024 Sep 11.
2
Retrospective Observational Study of Treatment Patterns and Efficacy of onabotulinumtoxinA Therapy in Patients with Refractory Overactive Bladder in Clinical Practice.回顾性观察研究:临床实践中,阿替卡因治疗难治性膀胱过度活动症的治疗模式和疗效。
Toxins (Basel). 2023 May 15;15(5):338. doi: 10.3390/toxins15050338.
3

本文引用的文献

1
Reviewing the ICS 2002 terminology report: The ongoing debate.回顾《2002年国际疾病分类术语报告》:持续的争论
Neurourol Urodyn. 2006;25(3):293. doi: 10.1002/nau.20251. Epub 2006 Apr 12.
2
Reliability and normal ranges for the Patient's Perception of Intensity of Urgency Scale in asymptomatic women.无症状女性患者对急迫性强度感知量表的信度和正常范围。
BJU Int. 2010 Mar;105(6):832-6. doi: 10.1111/j.1464-410X.2009.08846.x. Epub 2009 Oct 10.
3
Treatment with solifenacin increases warning time and improves symptoms of overactive bladder: results from VENUS, a randomized, double-blind, placebo-controlled trial.
Functional Polymorphism in the Gene, Encoding the Beta-3 Adrenergic Receptor, and Response to Intra-Detrusor Injection of Botulinum Toxin-A in Women with Overactive Bladder.
编码β-3肾上腺素能受体的基因中的功能多态性与膀胱过度活动症女性患者膀胱逼尿肌内注射A型肉毒杆菌毒素的反应
J Clin Med. 2022 Dec 17;11(24):7491. doi: 10.3390/jcm11247491.
4
Acupuncture for treating overactive bladder in adults.针刺治疗成人膀胱过度活动症。
Cochrane Database Syst Rev. 2022 Sep 23;9(9):CD013519. doi: 10.1002/14651858.CD013519.pub2.
5
Urodynamic evaluation of patients with localized prostate cancer before and 4 months after robotic radical prostatectomy.机器人辅助根治性前列腺切除术前和术后 4 个月局部前列腺癌患者的尿动力学评估。
Sci Rep. 2021 Feb 11;11(1):3632. doi: 10.1038/s41598-021-83143-x.
6
Which drugs are best for overactive bladder? From patients' expectations to physicians' decisions.哪些药物对膀胱过度活动症最有效?从患者的期望到医生的决策。
Int J Clin Pract. 2021 Apr;75(4):e13870. doi: 10.1111/ijcp.13870. Epub 2020 Dec 11.
7
Excitability and contractility in arterioles and venules from the urinary bladder.来自膀胱的小动脉和小静脉的兴奋性和收缩性。
Curr Top Membr. 2020;85:301-326. doi: 10.1016/bs.ctm.2020.01.003. Epub 2020 Feb 17.
8
NEW CONCEPTS IN BLADDER SENSATION AND URINARY URGENCY.膀胱感觉与尿急的新概念
Curr Bladder Dysfunct Rep. 2018;13(3):132-138. doi: 10.1007/s11884-018-0474-3. Epub 2018 Jun 5.
9
The efficacy of mirabegron in the treatment of urgency and the potential utility of combination therapy.米拉贝隆治疗尿急的疗效及联合治疗的潜在效用。
Ther Adv Urol. 2018 Jul 6;10(8):243-256. doi: 10.1177/1756287218781255. eCollection 2018 Aug.
10
The Overactive Bladder Symptom Score, International Prostate Symptom Score-Storage Subscore, and Urgency Severity Score in Patients With Overactive Bladder and Hypersensitive Bladder: Which Scoring System is Best?膀胱过度活动症和膀胱过敏患者的膀胱过度活动症症状评分、国际前列腺症状评分-储尿亚评分及尿急严重程度评分:哪种评分系统最佳?
Int Neurourol J. 2018 Jun;22(2):99-106. doi: 10.5213/inj.1832554.277. Epub 2018 Jun 30.
索利那新治疗可延长预警时间并改善膀胱过度活动症症状:来自VENUS一项随机、双盲、安慰剂对照试验的结果。
Urology. 2009 Jan;73(1):14-8. doi: 10.1016/j.urology.2008.08.485. Epub 2008 Nov 8.
4
Solifenacin in the treatment of urgency and other symptoms of overactive bladder: results from a randomized, double-blind, placebo-controlled, rising-dose trial.索利那新治疗膀胱过度活动症的尿急及其他症状:一项随机、双盲、安慰剂对照、剂量递增试验的结果
BJU Int. 2008 Nov;102(9):1120-7. doi: 10.1111/j.1464-410X.2008.07939.x. Epub 2008 Oct 6.
5
The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis.抗毒蕈碱药物治疗对膀胱过度活动症的影响:系统评价与荟萃分析的更新
Eur Urol. 2008 Sep;54(3):543-62. doi: 10.1016/j.eururo.2008.06.047. Epub 2008 Jun 20.
6
A population-based study of urinary symptoms and incontinence: the Canadian Urinary Bladder Survey.一项基于人群的泌尿系统症状与尿失禁研究:加拿大膀胱调查
BJU Int. 2008 Jan;101(1):52-8. doi: 10.1111/j.1464-410X.2007.07198.x. Epub 2007 Oct 1.
7
Urgency assessment in the evaluation of overactive bladder (OAB).膀胱过度活动症(OAB)评估中的紧迫性评估
Neurourol Urodyn. 2008;27(1):13-21. doi: 10.1002/nau.20472.
8
Overactive bladder syndrome among community-dwelling adults in Taiwan: prevalence, correlates, perception, and treatment seeking.台湾社区居住成年人的膀胱过度活动症:患病率、相关因素、认知及就医情况
Urol Int. 2006;77(4):327-33. doi: 10.1159/000096337.
9
Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study.五个国家基于人群的尿失禁、膀胱过度活动症及其他下尿路症状调查:EPIC研究结果
Eur Urol. 2006 Dec;50(6):1306-14; discussion 1314-5. doi: 10.1016/j.eururo.2006.09.019. Epub 2006 Oct 2.
10
A validated patient reported measure of urinary urgency severity in overactive bladder for use in clinical trials.一种经验证的、由患者报告的膀胱过度活动症尿急严重程度测量方法,用于临床试验。
J Urol. 2005 Aug;174(2):604-7. doi: 10.1097/01.ju.0000165461.38088.7b.